{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:40:41Z","timestamp":1792363241795,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3862-1","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T15:44:55Z","timestamp":1552578295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians"],"prefix":"10.1186","volume":"19","author":[{"given":"Lek","family":"Dysoley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saorin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimol","family":"Khim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bjorges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samphornarann","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chea","family":"Huch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Rekol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelli","family":"Westercamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Roca-Feltrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavuto","family":"Mukaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"3862_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12936-015-0714-3","volume":"14","author":"I Chen","year":"2015","unstructured":"Chen I, Poirot E, Newman M, Kandula D, Shah R, Hwang J, Cohen JM, Gosling R, Rooney L. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J. 2015;14:204.","journal-title":"Malar J"},{"issue":"2","key":"3862_CR2","first-page":"509","volume":"297","author":"LJ Bolchoz","year":"2001","unstructured":"Bolchoz LJ, Budinsky RA, McMillan DC, Jollow DJ. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001;297(2):509\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3862_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1124\/jpet.102.036921","volume":"303","author":"LJ Bolchoz","year":"2002","unstructured":"Bolchoz LJ, Morrow JD, Jollow DJ, McMillan DC. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology. J Pharmacol Exp Ther. 2002;303(1):141\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"3862_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000343123","volume":"39","author":"P Arese","year":"2012","unstructured":"Arese P, Gallo V, Pantaleo A, Turrini F. Life and death of Glucose-6-phosphate dehydrogenase (G6PD) deficient erythrocytes - role of redox stress and band 3 modifications. Transfus Med Hemother. 2012;39(5):328\u201334.","journal-title":"Transfus Med Hemother"},{"issue":"4","key":"3862_CR5","first-page":"213","volume":"61","author":"H Matsuoka","year":"2007","unstructured":"Matsuoka H, Thuan DT, van Thien H, Kanbe T, Jalloh A, Hirai M, Arai M, Dung NT, Kawamoto F. Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in lam Dong Province in southern Vietnam. Acta Med Okayama. 2007;61(4):213\u20139.","journal-title":"Acta Med Okayama"},{"issue":"10","key":"3862_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10038-004-0187-7","volume":"49","author":"H Matsuoka","year":"2004","unstructured":"Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T, Jalloh A, Lin K, Kawamoto F. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>a) is the most common variant in the Myanmar population. J Hum Genet. 2004;49(10):544\u20137.","journal-title":"J Hum Genet"},{"issue":"12","key":"3862_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028357","volume":"6","author":"S Kim","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One. 2011;6(12):e28357.","journal-title":"PLoS One"},{"key":"3862_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133\u2013201.","journal-title":"Adv Parasitol"},{"issue":"4","key":"3862_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4269\/ajtmh.2007.77.779","volume":"77","author":"E Beutler","year":"2007","unstructured":"Beutler E, Duparc S, Group GPDW. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77(4):779\u201389.","journal-title":"Am J Trop Med Hyg"},{"key":"3862_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1475-2875-12-209","volume":"12","author":"WR Taylor","year":"2013","unstructured":"Taylor WR, Widjaja H, Basri H, Tjitra E, Ohrt C, Taufik T, Baso S, Hoffman SL, Richie TL. Haemoglobin dynamics in Papuan and non-Papuan adults in Northeast Papua, Indonesia, with acute, uncomplicated vivax or falciparum malaria. Malar J. 2013;12:209.","journal-title":"Malar J"},{"issue":"5","key":"3862_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4269\/ajtmh.2001.65.614","volume":"65","author":"RN Price","year":"2001","unstructured":"Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65(5):614\u201322.","journal-title":"Am J Trop Med Hyg"},{"key":"3862_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12916-015-0441-1","volume":"13","author":"S Kheng","year":"2015","unstructured":"Kheng S, Muth S, Taylor WR, Tops N, Kosal K, Sothea K, Souy P, Kim S, Char CM, Vanna C, et al. Tolerability and safety of weekly primaquine against relapse of plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency. BMC Med. 2015;13:203.","journal-title":"BMC Med"},{"issue":"11","key":"3862_CR13","first-page":"631","volume":"55","author":"P Charoenlarp","year":"1972","unstructured":"Charoenlarp P, Areekul S, Harinasuta T, Sirivorasarn P. The haemolytic effect of a single dose of 45 mg of primaquine in G-6-PD deficient Thais. J Med Assoc Thail. 1972;55(11):631\u20138.","journal-title":"J Med Assoc Thail"},{"issue":"4","key":"3862_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4269\/ajtmh.1977.26.597","volume":"26","author":"WD Everett","year":"1977","unstructured":"Everett WD, Yoshida A, Pearlman E. Hemoglobin E and glucose-6-phosphate deficiency in the Khmer air force (Cambodia). Am J Trop Med Hyg. 1977;26(4):597\u2013601.","journal-title":"Am J Trop Med Hyg"},{"key":"3862_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12881-014-0093-6","volume":"15","author":"SS Shah","year":"2014","unstructured":"Shah SS, Macharia A, Makale J, Uyoga S, Kivinen K, Craik R, Hubbart C, Wellems TE, Rockett KA, Kwiatkowski DP, et al. Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya. BMC Med Genet. 2014;15:93.","journal-title":"BMC Med Genet"},{"issue":"1","key":"3862_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190272","volume":"13","author":"GJH Bastiaens","year":"2018","unstructured":"Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Goncalves BP, Affara M, Ouedraogo A, Bougouma EC, Sanou GS, et al. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: two open-label, randomized, safety trials. PLoS One. 2018;13(1):e0190272.","journal-title":"PLoS One"},{"issue":"8","key":"3862_CR17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/infdis\/jiy014","volume":"217","author":"I Chen","year":"2018","unstructured":"Chen I, Diawara H, Mahamar A, Sanogo K, Keita S, Kone D, Diarra K, Djimde M, Keita M, Brown J, et al. Safety of single-dose Primaquine in G6PD-deficient and G6PD-Normal males in Mali without malaria: an open-label, phase 1, dose-adjustment trial. J Infect Dis. 2018;217(8):1298\u2013308.","journal-title":"J Infect Dis"},{"issue":"4","key":"3862_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/cid\/cix355","volume":"65","author":"RC Tine","year":"2017","unstructured":"Tine RC, Sylla K, Faye BT, Poirot E, Fall FB, Sow D, Wang D, Ndiaye M, Ndiaye JL, Faye B, et al. Safety and efficacy of adding a single low dose of Primaquine to the treatment of adult patients with plasmodium falciparum malaria in Senegal, to reduce gametocyte carriage: a randomized controlled trial. Clin Infect Dis. 2017;65(4):535\u201343.","journal-title":"Clin Infect Dis"},{"key":"3862_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12936-016-1341-3","volume":"15","author":"R Mwaiswelo","year":"2016","unstructured":"Mwaiswelo R, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, Mmbando BP, Bjorkman A, Martensson A. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated plasmodium falciparum malaria in Tanzania. Malar J. 2016;15:316.","journal-title":"Malar J"},{"issue":"10","key":"3862_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001023","volume":"2","author":"S Shekalaghe","year":"2007","unstructured":"Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T. Primaquine clears submicroscopic plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One. 2007;2(10):e1023.","journal-title":"PLoS One"},{"issue":"5","key":"3862_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1128\/AAC.01135-09","volume":"54","author":"SA Shekalaghe","year":"2010","unstructured":"Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010;54(5):1762\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"3862_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12916-016-0581-y","volume":"14","author":"BP Goncalves","year":"2016","unstructured":"Goncalves BP, Tiono AB, Ouedraogo A, Guelbeogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, et al. Single low dose primaquine to reduce gametocyte carriage and plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. BMC Med. 2016;14:40.","journal-title":"BMC Med"},{"issue":"3","key":"3862_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151898","volume":"11","author":"G Bancone","year":"2016","unstructured":"Bancone G, Chowwiwat N, Somsakchaicharoen R, Poodpanya L, Moo PK, Gornsawun G, Kajeechiwa L, Thwin MM, Rakthinthong S, Nosten S, et al. Single low dose Primaquine (0.25 mg\/kg) does not cause clinically significant Haemolysis in G6PD deficient subjects. PLoS One. 2016;11(3):e0151898.","journal-title":"PLoS One"},{"issue":"6","key":"3862_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168702","volume":"12","author":"JT Lin","year":"2017","unstructured":"Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, Kuntawunginn W, My M, Thay K, Rahman R, et al. Single dose primaquine to reduce gametocyte carriage and plasmodium falciparum transmission in Cambodia: an open-label randomized trial. PLoS One. 2017;12(6):e0168702.","journal-title":"PLoS One"},{"issue":"10","key":"3862_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","volume":"10","author":"F Smithuis","year":"2010","unstructured":"Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010;10(10):673\u201381.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3862_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12936-017-1758-3","volume":"16","author":"S Heng","year":"2017","unstructured":"Heng S, Durnez L, Mao S, Siv S, Tho S, Mean V, Sluydts V, Coosemans M. Passive case detection of malaria in Ratanakiri Province (Cambodia) to detect villages at higher risk for malaria. Malar J. 2017;16(1):104.","journal-title":"Malar J"},{"key":"3862_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1475-2875-12-171","volume":"12","author":"N Khim","year":"2013","unstructured":"Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, et al. G6PD deficiency in plasmodium falciparum and plasmodium vivax malaria-infected Cambodian patients. Malar J. 2013;12:171.","journal-title":"Malar J"},{"issue":"12","key":"3862_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116143","volume":"9","author":"A Roca-Feltrer","year":"2014","unstructured":"Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, Tor P, Chuor CM, Kheng S, Siv S, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One. 2014;9(12):e116143.","journal-title":"PLoS One"},{"issue":"6","key":"3862_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa031688","volume":"350","author":"P Hillmen","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350(6):552\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"3862_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.actatropica.2009.10.011","volume":"113","author":"A Sowunmi","year":"2010","unstructured":"Sowunmi A, Gbotosho GO, Happi CT, Fateye BA. Factors contributing to anaemia after uncomplicated plasmodium falciparum malaria in children. Acta Trop. 2010;113(2):155\u201361.","journal-title":"Acta Trop"},{"issue":"2","key":"3862_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0950-3536(11)80022-3","volume":"5","author":"RE Phillips","year":"1992","unstructured":"Phillips RE, Pasvol G. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol. 1992;5(2):315\u201330.","journal-title":"Baillieres Clin Haematol"},{"issue":"10","key":"3862_CR32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S1473-3099(17)30524-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Hien TT, Thuy-Nhien NT, Dondorp AM, White NJ. Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam. Lancet Infect Dis. 2017;17(10):1022\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3862_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, Sam B, Dek D, Try V, Amato R, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16(3):357\u201365.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3862_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Chy S, Kim S, Ke S, Kloeung N, et al. A surrogate marker of piperaquine-resistant plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2017;17(2):174\u201383.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"3862_CR35","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1128\/AAC.48.4.1329-1334.2004","volume":"48","author":"S Pukrittayakamee","year":"2004","unstructured":"Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004;48(4):1329\u201334.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3862_CR36","first-page":"391","volume":"46","author":"J Arnold","year":"1955","unstructured":"Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, Jeffery GM. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med. 1955;46(3):391\u20137.","journal-title":"J Lab Clin Med"},{"issue":"17","key":"3862_CR37","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jama.1952.72930340022010b","volume":"149","author":"CB Clayman","year":"1952","unstructured":"Clayman CB, Arnold J, Hockwald RS, Yount EH Jr, Edgcomb JH, Alving AS. Toxicity of primaquine in Caucasians. J Am Med Assoc. 1952;149(17):1563\u20138.","journal-title":"J Am Med Assoc"},{"issue":"5","key":"3862_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0196-0644(99)70167-8","volume":"34","author":"RO Wright","year":"1999","unstructured":"Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34(5):646\u201356.","journal-title":"Ann Emerg Med"},{"issue":"12","key":"3862_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116063","volume":"9","author":"G Bancone","year":"2014","unstructured":"Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, White NJ, Nosten FH. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border. PLoS One. 2014;9(12):e116063.","journal-title":"PLoS One"},{"issue":"1","key":"3862_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12916-016-0701-8","volume":"14","author":"R Leang","year":"2016","unstructured":"Leang R, Khu NH, Mukaka M, Debackere M, Tripura R, Kheang ST, Chy S, Kak N, Buchy P, Tarantola A, et al. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia. BMC Med. 2016;14(1):171.","journal-title":"BMC Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3862-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3862-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3862-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:10:57Z","timestamp":1583885457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3862-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3862"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3862-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Cambodian National Ethics Committee and the U.S. Centers for Disease Control and Prevention and was approved the study, the latter as non-engagement in human subjects research. All subjects or their legal guardians gave written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was in the patient information sheet \/ consent from. No addition consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"250"}}